tenapanor
Drug Details
- Generic Name
- tenapanor
- Brand Names
- N/A
- Application Number
- Sponsor
- Patheon Pharmaceuticals Inc.
- NDC Codes
- 3
- Dosage Forms
- TABLET, FILM COATED
- Routes
- N/A
- Active Ingredients
- TENAPANOR, TENAPANOR HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE XPHOZAH is indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. XPHOZAH is a sodium hydrogen exchanger 3 (NHE3) inhibitor indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy ( 1 ).